Biohaven Ltd.
$13.62
-$0.27 (-1.94%)
$13.46Day Range$14.37
Key Statistics
Market Cap
$2.06B
Shares Outstanding
151.0M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Sep 23, 2022
Round Lot
100
Locale
US
Trading Data
Day Open
$14.07
Day High
$14.37
Day Low
$13.46
Volume
6.43M
VWAP
$13.75
Prev Close
$13.89
Transactions
--
Acc. Volume
--
About Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
PHARMACEUTICAL PREPARATIONSSIC 2834274 employees215 CHURCH STREET, NEW HAVEN, CT, 06510203-404-0410IPO Sep 23, 2022US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001935979
- Ticker Root
- BHVN
- SIC Code
- 2834
About Biohaven Ltd. (BHVN) Stock
Biohaven Ltd. (BHVN) closed the 2026-09-18 session at $13.62, down 1.94% versus the previous close (-0.27). The stock opened at $14.07 and traded between $13.46 and $14.37 during that session. Session trading volume was 6.4M shares. The volume-weighted average price (VWAP) is $13.75.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Biohaven Ltd. has a market capitalization of $2.06 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. BHVN is listed on the XNYS exchange. The company employs approximately 274 people. Biohaven Ltd. is headquartered in NEW HAVEN, CT. The recorded listing date is 2022-09-23.
On this page you can find market BHVN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.